Literature DB >> 24599013

Validation study of automated oscillometric measurement of the ankle-brachial index for lower arterial occlusive disease by comparison with computed tomography angiography.

Shigeo Ichihashi1, Tomoko Hashimoto2, Shinichi Iwakoshi1, Kimihiko Kichikawa1.   

Abstract

The ankle-brachial index (ABI) determined by the oscillometric method has been shown to reliably detect peripheral arterial disease (PAD), with highly correlations with the Doppler method. However, most of these studies were shown in cohorts with a small number of PAD patients, and no imaging studies have been performed. The purpose of this study is to evaluate the diagnostic accuracy and optimal threshold of oscillometric ABI for detecting PAD using computed tomography angiography (CTA) as a gold standard in a cohort that consists mostly of PAD patients. This retrospective study included 108 consecutive patients with 216 limbs. ABI measured by an oscillometric device was compared with CTA. The diagnostic accuracy of oscillometric ABI to detect ≥50% and ≥75% stenosis confirmed by CTA and the optimal ABI cutoff values were evaluated using receiver operating characteristic (ROC) curve analysis. The oscillometric ABI could not be measured in nine limbs. The mean ABI was 0.72±0.31. The areas under the ROC curves (AUCs) for detecting ≥50% and ≥75% stenosis with oscillometric ABI were 0.919 and 0.918, respectively. The optimal ABI cutoff values to detect these levels of stenosis were 0.99 (sensitivity, 90%: specificity, 85%) and 0.87 (sensitivity, 84%: specificity, 89%), respectively. If patients with diabetes mellitus (DM) were analyzed separately, the AUC for detecting ≥75% stenosis was 0.888. Oscillometric ABI had a high diagnostic accuracy to detect PAD using CTA as a gold standard. The diagnostic ability of ABI to detect PAD could be impaired by the presence of DM.

Entities:  

Mesh:

Year:  2014        PMID: 24599013     DOI: 10.1038/hr.2014.34

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  7 in total

1.  Combination of pulse volume recording (PVR) parameters and ankle-brachial index (ABI) improves diagnostic accuracy for peripheral arterial disease compared with ABI alone.

Authors:  Tomoko Hashimoto; Shigeo Ichihashi; Shinichi Iwakoshi; Kimihiko Kichikawa
Journal:  Hypertens Res       Date:  2016-02-25       Impact factor: 3.872

2.  Metabolomic signature of arterial stiffness in male patients with peripheral arterial disease.

Authors:  Maksim Zagura; Jaak Kals; Kalle Kilk; Martin Serg; Priit Kampus; Jaan Eha; Ursel Soomets; Mihkel Zilmer
Journal:  Hypertens Res       Date:  2015-07-02       Impact factor: 3.872

Review 3.  Current therapies and investigational drugs for peripheral arterial disease.

Authors:  Jun-Ichi Suzuki; Munehisa Shimamura; Hiroyuki Suda; Kouji Wakayama; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Mitsuaki Isobe; Issei Komuro; Ryuichi Morishita
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

4.  Automated plethysmographic measurement of the ankle-brachial index: a comparison with the doppler ultrasound method.

Authors:  Jane H Davies; E Mark Williams
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

5.  Detection of peripheral arterial disease with an improved automated device: comparison of a new oscillometric device and the standard Doppler method.

Authors:  Matjaž Špan; Gregor Geršak; Sandrine C Millasseau; Marko Meža; Andrej Košir
Journal:  Vasc Health Risk Manag       Date:  2016-07-29

6.  Assessment of peripheral artery disease risk in building construction workers by Ankle-Brachial index measurement with automated oscillometric and hand-held Doppler device.

Authors:  Manish K Verma; Vibha Gangwar; Rajani B Jasrotia; Nitin A John
Journal:  J Family Med Prim Care       Date:  2022-01-31

7.  The ankle brachial index in people with and without diabetes: intra-tester reliability.

Authors:  Sarah Louise Casey; Sean Michael Lanting; Vivienne Helaine Chuter
Journal:  J Foot Ankle Res       Date:  2020-05-12       Impact factor: 2.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.